REG - Benchmark Hlgs PLC - Notice of Q2 and Interim Results
RNS Number : 7967VBenchmark Holdings PLC19 April 202119 April 2021
Benchmark Holdings plc
("Benchmark" or the "Company")
Notice of Q2 and Interim Results
Webcast for analysts and institutional investors
Equity Development webcast for retail investors
Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will announce its Q2 and Interim results for the three and six month periods ended 31 March 2021, on Tuesday 18 May 2021.
Webcast for analysts and institutional investors at 9am UK time
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a webcast for analysts and institutional investors on that day at 09:00am UK time. To register your interest, please contact benchmark@mhpc.com.
Equity Development webcast for retail investors at 12:30pm UK time
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a separate webcast for retail investors and wealth managers at 12.30pm UK time. The webcast is open to all existing and potential shareholders. Questions can be submitted during the presentation which will be addressed at the end.
To register please visit: https://www.equitydevelopment.co.uk/news-and-events/benchmark-holdings-interim-results-investor-presentation-18th-may-2021.
Enquiries
For further information, please contact:
Benchmark Holdings plc
Tel: 020 3696 0630
Trond Williksen, CEO
Septima Maguire, CFO
Ivonne Cantu, Investor Relations
Numis (Broker and NOMAD)
Tel: 020 7260 1000
James Black, Freddie Barnfield, Duncan Monteith
MHP Communications
Tel: 020 3128 8990
Katie Hunt, Reg Hoare, Alistair de Kare-Silver, Charlie Protheroe
benchmark@mhpc.com
Equity Development
Hannah Crowe
Tel: 020 7065 2690
About Benchmark
Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.
We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDNORIFMFTMTTBBPB
Recent news on Benchmark Holdings
See all newsREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Benchmark Hlgs PLC - Total Voting Rights
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
Announcement